Patents by Inventor LaTasha B. Craig

LaTasha B. Craig has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and compositions for treating diseases and conditions associated with gonadotropin releasing hormone receptor
    Patent number: 11530239
    Abstract: The disclosure is directed in non-limiting embodiments to compounds, compositions, and methods of treating conditions and diseases associated with activation of the gonadotropin GnRH receptor (GnRHR), particularly those involving GnRHR activating autoantibodies (GnRHR AAbs). In one non-limiting embodiment, the disease is Polycystic Ovary Syndrome (PCOS). The therapeutic compounds in at least certain embodiments include peptides which at least partially comprise D-amino acids, such as retro-inverso D-amino acid (RID) peptides, which are able to bind with high affinity to GnRHR AAbs.
    Type: Grant
    Filed: March 4, 2021
    Date of Patent: December 20, 2022
    Assignee: The Board of Regents of the University of Oklahoma
    Inventors: David C. Kem, Xichun Yu, Hongliang Li, LaTasha B. Craig
  • Methods and Compositions for Treating Diseases and Conditions Associated with Gonadotropin Releasing Hormone Receptor
    Publication number: 20210198318
    Abstract: The disclosure is directed in non-limiting embodiments to compounds, compositions, and methods of treating conditions and diseases associated with activation of the gonadotropin GnRH receptor (GnRHR), particularly those involving GnRHR activating autoantibodies (GnRHR AAbs). In one non-limiting embodiment, the disease is Polycystic Ovary Syndrome (PCOS). The therapeutic compounds in at least certain embodiments include peptides which at least partially comprise D-amino acids, such as retro-inverso D-amino acid (RID) peptides, which are able to bind with high affinity to GnRHR AAbs.
    Type: Application
    Filed: March 4, 2021
    Publication date: July 1, 2021
    Inventors: David C. KEM, Xichun YU, Hongliang LI, LaTasha B. CRAIG
  • Methods and compositions for treating diseases and conditions associated with gonadotropin releasing hormone receptor
    Patent number: 10975124
    Abstract: The disclosure is directed in non-limiting embodiments to compounds, compositions, and methods of treating conditions and diseases associated with activation of the gonadotropin GnRH receptor (GnRHR), particularly those involving GnRHR activating autoantibodies (GnRHR AAbs). In one non-limiting embodiment, the disease is Polycystic Ovary Syndrome (PCOS). The therapeutic compounds in at least certain embodiments include peptides which at least partially comprise D-amino acids, such as retro-inverso D-amino acid (RID) peptides, which are able to bind with high affinity to GnRHR AAbs.
    Type: Grant
    Filed: February 13, 2019
    Date of Patent: April 13, 2021
    Assignee: The Board of Regents of the University of Oklahoma
    Inventors: David Charles Kem, Xichun Yu, Hongliang Li, LaTasha B. Craig
  • Methods and Compositions for Treating Diseases and Conditions Associated with Gonadotropin Releasing Hormone Receptor
    Publication number: 20190263862
    Abstract: The disclosure is directed in non-limiting embodiments to compounds, compositions, and methods of treating conditions and diseases associated with activation of the gonadotropin GnRH receptor (GnRHR), particularly those involving GnRHR activating autoantibodies (GnRHR AAbs). In one non-limiting embodiment, the disease is Polycystic Ovary Syndrome (PCOS). The therapeutic compounds in at least certain embodiments include peptides which at least partially comprise D-amino acids, such as retro-inverso D-amino acid (RID) peptides, which are able to bind with high affinity to GnRHR AAbs.
    Type: Application
    Filed: February 13, 2019
    Publication date: August 29, 2019
    Inventors: David Charles Kem, Xichun Yu, Hongliang Li, LaTasha B. Craig